CoChat
Sign Up
Cited by 35

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

The PD-1:PD-L1 immune inhibitory checkpoint in Helicobacter pylori infection and gastric cancer: a comprehensive review and future perspectives

Silva, Rui, Gullo, Irene, Carneiro, Fátima·2016·Porto Biomedical Journal
DOI 10.1016/j.pbj.2016.03.004
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pbj.2016.03.004

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 42

  1. Hartgrink, 2009, Gastric cancer., Lancet, 374, 477, 10.1016/S0140-6736(09)60617-6 · DOI
  2. Hundahl, 2000, The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy., Cancer, 88, 921, 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S · DOI
  3. Lauren, 1965, The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma. An attempt at a histo-clinical classification., Acta Pathol Microbiol Scand, 64, 31, 10.1111/apm.1965.64.1.31 · DOI
  4. Hanahan, 2011, Hallmarks of cancer: the next generation., Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  5. Hanahan, 2012, Accessories to the crime: functions of cells recruited to the tumor microenvironment., Cancer Cell, 21, 309, 10.1016/j.ccr.2012.02.022 · DOI · Paper page
  6. Dunn, 2002, Cancer immunoediting: from immunosurveillance to tumor escape., Nat Immunol, 3, 991, 10.1038/ni1102-991 · DOI · Paper page
  7. DuPage, 2012, Expression of tumour-specific antigens underlies cancer immunoediting., Nature, 482, 405, 10.1038/nature10803 · DOI
  8. Koebel, 2007, Adaptive immunity maintains occult cancer in an equilibrium state., Nature, 450, 903, 10.1038/nature06309 · DOI
  9. Fridman, 2011, Prognostic and predictive impact of intra and peritumoral immune infiltrates., Cancer Res, 71, 5601, 10.1158/0008-5472.CAN-11-1316 · DOI
  10. Pages, 2010, Immune infiltration in human tumors: a prognostic factor that should not be ignored., Oncogene, 29, 1093, 10.1038/onc.2009.416 · DOI
  11. Keir, 2008, PD-1 and its ligands in tolerance and immunity., Annu Rev Immunol, 26, 677, 10.1146/annurev.immunol.26.021607.090331 · DOI · Paper page
  12. Mazanet, 2002, B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis., J Immunol, 169, 3581, 10.4049/jimmunol.169.7.3581 · DOI
  13. Latchman, 2004, PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells., Proc Natl Acad Sci U S A, 101, 10691, 10.1073/pnas.0307252101 · DOI
  14. Krupnick, 2005, Murine vascular endothelium activates and induces the generation of allogeneic CD425Foxp3 regulatory T cells., J Immunol, 175, 6265, 10.4049/jimmunol.175.10.6265 · DOI
  15. Beswick, 2007, Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4 CD25 FoxP3 regulatory T cells., Infect Immun, 75, 4334, 10.1128/IAI.00553-07 · DOI
  16. Pardoll, 2012, The blockade of immune checkpoints in cancer immunotherapy., Nat Rev Cancer, 12, 252, 10.1038/nrc3239 · DOI · Paper page
  17. Afreen, 2014, The immunoinhibitory B7-H1 molecule as a potential target in cancer: killing many birds with one stone., Hematol Oncol Stem Cell Ther, 7, 1, 10.1016/j.hemonc.2013.09.005 · DOI
  18. Wu, 2006, Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance., Acta Histochem, 108, 19, 10.1016/j.acthis.2006.01.003 · DOI
  19. Sun, 2007, PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies., Tissue Antigens, 69, 19, 10.1111/j.1399-0039.2006.00701.x · DOI
  20. Hou, 2014, Correlation between infiltration of FOXP3 regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer., Exp Mol Pathol, 96, 284, 10.1016/j.yexmp.2014.03.005 · DOI
  21. Dong, 2002, Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion., Nat Med, 8, 793, 10.1038/nm730 · DOI · Paper page
  22. Parsa, 2007, Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma., Nat Med, 13, 84, 10.1038/nm1517 · DOI
  23. Ye, 2009, Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion., J Surg Oncol, 100, 500, 10.1002/jso.21376 · DOI
  24. Iwai, 2002, Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade., Proc Natl Acad Sci U S A, 99, 12293, 10.1073/pnas.192461099 · DOI
  25. Wolchok, 2014, Cancer: Antitumour immunity gets a boost., Nature, 515, 496, 10.1038/515496a · DOI
  26. Tumeh, 2014, PD-1 blockade induces responses by inhibiting adaptive immune resistance., Nature, 515, 568, 10.1038/nature13954 · DOI · Paper page
  27. Brahmer, 2012, Safety and activity of anti-PD-L1 antibody in patients with advanced cancer., N Engl J Med, 366, 2455, 10.1056/NEJMoa1200694 · DOI · Paper page
  28. Herbst, 2014, Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients., Nature, 515, 563, 10.1038/nature14011 · DOI · Paper page
  29. Powles, 2014, MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer., Nature, 515, 558, 10.1038/nature13904 · DOI
  30. Ernst, 2000, The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer., Annu Rev Microbiol, 54, 615, 10.1146/annurev.micro.54.1.615 · DOI · Paper page
  31. Knipp, 1994, Suppression of human mononuclear cell response by Helicobacter pylori: effects on isolated monocytes and lymphocytes., FEMS Immunol Med Microbiol, 8, 157, 10.1111/j.1574-695X.1994.tb00438.x · DOI
  32. Wang, 2000, Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through FasFas ligand interactions., Infect Immun, 68, 4303, 10.1128/IAI.68.7.4303-4311.2000 · DOI
  33. Molinari, 1998, Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA., J Exp Med, 187, 135, 10.1084/jem.187.1.135 · DOI
  34. Gebert, 2003, Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation., Science, 301, 1099, 10.1126/science.1086871 · DOI
  35. Ye, 1997, Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4 T cell activation during Helicobacter pylori infection., J Clin Invest, 99, 1628, 10.1172/JCI119325 · DOI
  36. Das, 2006, Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection., J Immunol, 176, 3000, 10.4049/jimmunol.176.5.3000 · DOI
  37. Wu, 2010, Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection., Clin Exp Immunol, 161, 551, 10.1111/j.1365-2249.2010.04217.x · DOI
  38. Wang, 2012, A frequent somatic mutation in CD274 3-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding., Hum Mutat, 33, 480, 10.1002/humu.22014 · DOI
  39. Chen, 2003, In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma., World J Gastroenterol, 9, 1370, 10.3748/wjg.v9.i6.1370 · DOI
  40. Wang, 2013, A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma., Hum Genet, 132, 641, 10.1007/s00439-013-1275-6 · DOI
  41. Zheng, 2014, Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications., Chin J Cancer Res, 26, 104
  42. 2014, Comprehensive molecular characterization of gastric adenocarcinoma., Nature, 513, 202, 10.1038/nature13480 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Silva, R., Gullo, I., & Carneiro, F.
Venue
Porto Biomedical Journal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2016-03
Volume
1
Issue
1
Pages
4-11
ISSN
2444-8664
DOI
10.1016/j.pbj.2016.03.004
Cited by
35
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review